EUVIMEDEUVIMED entdecken
MetaanalyseOpen Access · CC BY 4.0

A meta-analysis of the correlation between carbapenem antibiotic use and the incidence of carbapenem-resistant Pseudomonas aeruginosa

Cheng Tang, Yaosheng Mei, Hang Fang, Wei Wang, Meiyan Lv

The Journal of Infection in Developing Countries · 2025

DOI: 10.3855/jidc.20950 ↗

Kurz gefasst

Metaanalyse in der Zeitschrift The Journal of Infection in Developing Countries, 2025. Verfasst von Cheng Tang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Laboratory, The First People's Hospital of Yongkang, Yongkang City, Zhejiang Province, 321300, China. Hauptthemen laut MEDLINE: Pseudomonas aeruginosa, Pseudomonas Infections, Carbapenems, Anti-Bacterial Agents. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

This meta-analysis evaluates the correlation between carbapenem antibiotic use and the incidence of carbapenem-resistant Pseudomonas aeruginosa (CRPA). Methodology: A comprehensive literature search conducted across multiple databases yielded seven clinical experimental studies involving 4,417 patients. The primary outcomes assessed were the risk factors associated with CRPA infection, drug resistance rates, and the comparison of resistance rates between meropenem (MEM) and imipenem (IPM). The Newcastle-Ottawa Scale (NOS) was used to assess study quality, and Egger’s test and funnel plots were used to assess publication bias.

Results

The NOS scores for the included studies ranged between 6 and 8, indicating their generally high quality. The analysis indicated that prior carbapenem use significantly increased the risk of CRPA infection (OR = 1.866, 95% confidence interval [CI]: 1.164–2.993, p = 0.010). The drug resistance rates of P. aeruginosa to carbapenems ranged between 21.07% and 37.90%. There was no significant difference in drug resistance rates between MEM and IPM (risk ratio = 1.09, 95% CI: 0.99-1.21, p = 0.517).

Conclusions

With drug resistance rates between 21.07% and 37.90%, these findings suggest that carbapenem use is associated with an increased risk of CRPA infection, highlighting the need for the judicious use of these antibiotics in clinical practice.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pseudomonas aeruginosaPseudomonas InfectionsCarbapenemsAnti-Bacterial Agentsbeta-Lactam ResistanceDrug Resistance, BacterialHumansIncidenceRisk FactorsMeropenem

Stichwörter der Autor:innen

Meta-analysiscarbapenem antibioticcarbapenem-resistant Pseudomonas aeruginosadrug resistance rates

Substanzen

CarbapenemsAnti-Bacterial AgentsMeropenem

Autor:innen und Institutionen

  • Department of Clinical Laboratory, The First People's Hospital of Yongkang, Yongkang City, Zhejiang Province, 321300, China.
  • Department of Cardiology, The First People's Hospital of Yongkang, Yongkang City, Zhejiang Province, 321300, China.

Zitieren

APA

Tang, C., Mei, Y., Fang, H., Wang, W., & Lv, M. (2025). A meta-analysis of the correlation between carbapenem antibiotic use and the incidence of carbapenem-resistant Pseudomonas aeruginosa. The Journal of Infection in Developing Countries. https://doi.org/10.3855/jidc.20950

Vancouver

Tang C, Mei Y, Fang H, Wang W, Lv M. A meta-analysis of the correlation between carbapenem antibiotic use and the incidence of carbapenem-resistant Pseudomonas aeruginosa. The Journal of Infection in Developing Countries. 2025. doi:10.3855/jidc.20950

BibTeX
@article{Tang2025,
  author = {Tang, Cheng and Mei, Yaosheng and Fang, Hang and Wang, Wei and Lv, Meiyan},
  title = {A meta-analysis of the correlation between carbapenem antibiotic use and the incidence of carbapenem-resistant Pseudomonas aeruginosa},
  journal = {The Journal of Infection in Developing Countries},
  year = {2025},
  doi = {10.3855/jidc.20950}
}
Kostenlos starten →